Selank is a promising peptide that has gained significant attention in the field of neuroscience and psychopharmacology due to its potential therapeutic benefits. This article delves into the intricacies of SELANK, elucidating its properties, mechanisms of action, and the scientific evidence that supports its use in various applications.
Research and studies have provided evidence of SELANK’s role in enhancing BDNF levels. For example, a study published titled Intranasal Administration of the Peptide Selank Regulates BDNF Expression in the Rat Hippocampus in vivo demonstrated that SELANK “Selank significantly increased the concentration of BDNF mRNA in the hippocampus” and “The influence of Selank intranasal administration on the BDNF gene protein product level was estimated at the next stage of the study. A statistically significant 30% increase relative to the control value was found in the rat hippocampus BDNF level 24 h after the peptide administration at a dose of 250 or 500 μg/kg body weight” showing administration significantly increased BDNF expression in the rat hippocampus, suggesting a potential role in improving cognitive function and neuroprotection.